Your FAQs Around Surgeries for Advanced Bladder Cancer

Several surgical strategies are available for advanced bladder cancer, including cystectomy and transurethral resection of the bladder tumor (TURBT). Each approach carries its own potential risks, side effects, and likelihood of recurrence.

Bladder cancer is classified as advanced when it extends beyond the bladder and invades nearby tissues. At this stage, many patients are concerned about survival rates, treatment effectiveness, and the possibility of Bladder cancer recurrence after 3 months or later.

Depending on the extent of spread, oncologists may describe the disease as locally advanced or metastatic. Advanced bladder cancer generally corresponds to stage 3B or stage 4.

Chemotherapy or immunotherapy is commonly the first-line treatment for advanced bladder cancer. However, surgery may still play a key role in disease management, symptom control, and potentially improving survival outcomes.

Below, we address frequently asked questions about surgical treatment for advanced bladder cancer, including what to expect after surgery and how recurrence risk is monitored.

What types of surgery are available for advanced bladder cancer?

Two primary surgical procedures are used to diagnose and treat bladder cancer:

• transurethral resection of the bladder tumor (TURBT)
• cystectomy

During a TURBT, a surgeon removes the tumor from the bladder lining and muscle using a thin instrument passed through the urethra. Either general or local anesthesia is administered to reduce discomfort during the procedure.

TURBT also allows physicians to directly visualize and evaluate the tumor. However, it is not usually considered a first-line treatment except in situations involving recurrent bladder cancer.

In certain cases, surgeons apply an electrical current or laser to eliminate any remaining cancer cells after tumor removal. This process is known as fulguration and may help lower the risk of early recurrence.

For advanced bladder cancer, TURBT is often performed after chemotherapy, radiation therapy, or both have been used to shrink the tumor. If the tumor cannot be fully removed or destroyed with these therapies, a cystectomy may be recommended.

A cystectomy involves removing part or all of the bladder. When the entire bladder is removed — called a radical cystectomy — reconstructive surgery is required to reroute urine through the intestines. In some cases, surgeons create a new bladder (neobladder) from a segment of the intestine. Patients frequently ask Can bladder cancer return after bladder removal, and while radical cystectomy significantly reduces risk, recurrence can still occur in certain situations, making close follow-up essential.

What should I expect after bladder tumor removal?

Treatment typically does not end once the bladder tumor has been surgically removed, particularly in advanced bladder cancer. Many individuals continue with chemotherapy, immunotherapy, or radiation therapy. If the tumor persists or regrows, additional surgical procedures may be necessary.

Even when the tumor appears to be completely excised, ongoing surveillance is critical. Experts estimate that approximately half  of patients will experience recurrence within 12 months after a TURBT, despite additional treatment. This includes concerns about Bladder cancer recurrence after 3 months, which is why structured monitoring protocols are implemented.

After a TURBT, surveillance for recurrence may include:

• cystoscopy every 3 months
• imaging of the urinary system and chest every 3 to 6 months
• blood tests every 3 to 6 months
• urine tests every 6 to 12 months

If no cancer is detected after 5 years, follow-up visits may become less frequent. Ongoing monitoring decisions are made collaboratively between the patient and healthcare team, based on medical history, tumor characteristics, and overall health.

If recurrence occurs, management options may include additional medication, repeat TURBT, or consideration of cystectomy. Early identification of recurrence — including Bladder cancer recurrence after 3 months — allows for prompt intervention and improved disease control.

What are the side effects of surgery?

Side effects from TURBT are usually mild and temporary. Patients may notice minor bleeding or discomfort during urination in the first few days following surgery. If fulguration is performed, temporary bladder irritation can also occur.

Undergoing multiple TURBT procedures may lead to scarring within the bladder. Over time, this scarring can reduce bladder capacity, resulting in more frequent urination and possible urinary urgency or incontinence.

Frequent urination may also occur after a partial cystectomy because the bladder is smaller and holds less urine.

After a radical cystectomy, urine exits the body through a urostomy or abdominal opening known as a stoma. Complications associated with this approach can include:

• infections
• urine leakages or blockage
• incontinence (loss of bladder control)
• pouch stones

In some cases, tissues from the prostate gland, seminal vesicles, or vagina are removed during cystectomy. This can result in sexual side effects such as erectile dysfunction or vaginal dryness. When appropriate, nerve-sparing techniques or reconstructive options may help preserve or restore sexual function.

Research  indicates that side effects differ depending on the type of urinary reconstruction performed. Quality of life, body image, and emotional well-being may also be affected. Open communication with your oncologist and surgeon about your lifestyle priorities can help tailor treatment decisions to your individual needs.

How many times can you receive TURBT for bladder cancer?

TURBT can be repeated to remove recurrent tumors, and there is no strict limit on how many times it may be performed. However, the risks and benefits must be carefully weighed.

Typically, TURBT is conducted at diagnosis to assess how deeply the cancer has invaded the bladder. In many situations, a repeat TURBT is advised after initial chemotherapy or radiation therapy to evaluate tumor response.

Up to five  repeat TURBT procedures have been documented in patients with bladder cancer. However, available evidence does not clearly establish whether multiple procedures improve survival or significantly reduce relapse . Repeated resections may increase the risk of bladder scarring and functional impairment.

What is the life expectancy of someone with advanced bladder cancer?

Life expectancy for individuals with advanced bladder cancer varies widely and depends largely on the degree of cancer spread.

When cancer has spread to nearby lymph nodes but remains within the pelvis, the 5-year relative survival rate  is approximately 41%. This figure compares survival among people with cancer to those without cancer over a five-year period.

If the cancer spreads beyond the pelvis to distant organs, prognosis becomes more limited. The 5-year relative survival rate for metastatic bladder cancer is about 9% .

Patients who undergo bladder removal often ask about Life expectancy after bladder removal for cancer. Outcomes depend on tumor stage, lymph node involvement, overall health, and response to additional treatments such as chemotherapy or immunotherapy.

Will surgery improve my life expectancy?

Research  suggests that survival outcomes tend to be better after radical cystectomy compared with bladder-preserving trimodal therapy, which includes TURBT, chemoradiation therapy, and active surveillance.

Even so, individuals with advanced bladder cancer generally have shorter life expectancies than those diagnosed with localized tumors. Nevertheless, surgical intervention may offer meaningful survival benefits in appropriately selected patients.

According to the National Cancer Institute, the 5-year cancer-specific survival rate for tumors that have extended beyond the bladder to nearby lymph nodes or organs is 39% .

For metastatic bladder cancer — where the disease has spread to distant sites — the 5-year cancer-specific survival rate is 8% .

A 2023 study of 2,047 people with bladder cancer in Finland found a 5-year cancer-specific survival rate of 47% among those with tumor spread after radical cystectomy. In that group, the 10-year cancer-specific survival rate was 44%.

The takeaway

Advanced bladder cancer is associated with lower survival rates, but surgery may enhance outcomes for certain patients.

Different surgical options carry varying risks of complications and recurrence, including the possibility of Bladder cancer recurrence after 3 months or later. Complications are more common following cystectomy, yet survival results are often superior compared with TURBT alone.

If you are weighing TURBT versus cystectomy, a detailed discussion with your oncologist and surgeon can help clarify which approach aligns best with your medical condition, personal goals, and quality-of-life considerations.